World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
68
Citations
21289
World Ranking
2135
National Ranking
74

Medicine

D-Index
80
Citations
27934
World Ranking
16980
National Ranking
569

Bruce W. S. Robinson publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Bruce W. S. Robinson sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 248 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Bruce W. S. Robinson D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Bruce W. S. Robinson sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 68 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Bruce W. S. Robinson is a researcher affiliated with the University of Western Australia in Australia. Their academic work largely focuses on medical and immunological fields, with substantial contributions to oncology and pulmonary medicine.

Their publications cover a range of topics primarily centered on cancer immunotherapy and immune responses, including areas such as biomarkers and treatments relevant to occupational and environmental lung diseases. Additional research interests extend to CAR-T cell therapy, cancer research and treatments, vaccines, immunoinformatics approaches, and neuroendocrine tumor research advances.

Frequent publication venues for their work include:

  • Cancer Immunology Immunotherapy
  • Proceedings of the National Academy of Sciences
  • Vaccines
  • Journal of Thoracic Oncology
  • Cancer Discovery

Notable recent papers authored or co-authored by Bruce W. S. Robinson include:

  • "Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies" (2021), published in Proceedings of the National Academy of Sciences
  • "Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used" (2021), published in Cancer Immunology Immunotherapy
  • "The Current Lung Cancer Neoantigen Landscape and Implications for Therapy" (2021), published in Journal of Thoracic Oncology
  • "The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19" (2022), published in Vaccines
  • "Verification of a Blood-Based Targeted Proteomics Signature for Malignant Pleural Mesothelioma" (2020), published in Cancer Epidemiology Biomarkers & Prevention

Their collaborative network includes frequent co-authors such as Jenette Creaney, Alec Redwood, Ian M. Dick, Jonathan Chee, and Anna K. Nowak. These collaborations indicate a breadth of interdisciplinary research within the field of cancer immunology and related biomedical sciences.

Bruce W. S. Robinson's main fields of study are medicine and immunology and microbiology, with emphases on oncology, immunology, pulmonary and respiratory medicine, molecular biology, and biotechnology as subfields. Their research spans over 42 publications in medicine and 11 in immunology and microbiology.

Main topics of their work include:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Occupational and environmental lung diseases
  • CAR-T cell therapy research
  • Cancer Research and Treatments
  • Vaccines and immunoinformatics approaches
  • Neuroendocrine Tumor Research Advances

Best Publications

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

    J. Nangalia;C.E. Massie;E.J. Baxter;F.L. Nice

  • Advances in Malignant Mesothelioma

    Bruce W.S. Robinson;Richard A. Lake

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Immunotherapy and chemotherapy — a practical partnership

    Richard A. Lake;Bruce W.S. Robinson

  • Mesothelin-family proteins and diagnosis of mesothelioma.

    Bruce W S Robinson;Jenette Creaney;Richard Lake;Anna Nowak

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Integrative Molecular Characterization of Malignant Pleural Mesothelioma

    Julija Hmeljak;Francisco Sanchez-Vega;Katherine A. Hoadley;Juliann Shih

  • Cross-priming in health and disease.

    Christian Kurts;Bruce W. S. Robinson;Percy A. Knolle

  • Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T Cells

    Anna K Nowak;Richard A Lake;Amanda L Marzo;Amanda L Marzo;Bernadette Maree Scott;Bernadette Maree Scott

  • Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.

    B W Robinson;T L McLemore;R G Crystal

  • Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.

    Anna K Nowak;Bruce W S Robinson;Richard A Lake

  • Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity

    Amanda L. Marzo;Beverley F. Kinnear;Richard A. Lake;Jeffrey J. Frelinger

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study

    M. J. Byrne;J. A. Davidson;A. W. Musk;J. Dewar

  • Programmed Death Ligand 2 in Cancer-Induced Immune Suppression

    Esdy N. Rozali;Stanleyson V. Hato;Bruce W. Robinson;Richard A. Lake

  • Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

    Joshua D. Campbell;Joshua D. Campbell;Joshua D. Campbell;Christina Yau;Christina Yau;Reanne Bowlby;Yuexin Liu

  • Immunotherapy for lung cancer

    Antonius Steven;Scott A. Fisher;Bruce W. Robinson

  • Genetic ‘risk’ for atopy is associated with delayed postnatal maturation of T‐cell competence

    P.G. Holt;J.B. Clough;B.J. Holt;M.J. Baron-Hay

  • Gemcitabine Exerts a Selective Effect on the Humoral Immune Response Implications for Combination Chemo-immunotherapy

    Anna K Nowak;Bruce W S Robinson;Richard A Lake

Frequent Co-Authors

Richard A. Lake
Richard A. Lake University of Western Australia
Arthur W. Musk
Arthur W. Musk University of Western Australia
Anna K. Nowak
Anna K. Nowak University of Western Australia
Helle Bielefeldt-Ohmann
Helle Bielefeldt-Ohmann University of Queensland
Harvey I. Pass
Harvey I. Pass New York University
John W. Upham
John W. Upham University of Queensland
Patrick G. Holt
Patrick G. Holt University of Western Australia
Robert A. Holt
Robert A. Holt BC Cancer Research Institute
Lyle J. Palmer
Lyle J. Palmer University of Adelaide
Nicholas de Klerk
Nicholas de Klerk University of Western Australia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens doors to diverse career paths, many of which can be further enhanced through related online degrees. For those interested in healthcare and patient interaction, becoming a child life specialists salary offers promising opportunities. These specialists support children through medical experiences, blending knowledge of biology with compassionate care.

Online education also provides accessible options for individuals facing unique challenges. For example, understanding what is the best degree for a convicted felon can guide prospective students toward degree programs with strong employment prospects after conviction, ensuring a fresh start in scientific or healthcare fields.

For those drawn to patient-centered, holistic healthcare, degrees leading to a career as a functional medicine nurse salary can integrate microbiology knowledge with nursing and holistic practices, making it a rewarding option.

Alternatively, if you are interested in the administrative and data side of healthcare, certification as a certified professional coder offers a steady career with growth potential. These roles often complement scientific backgrounds and provide versatility in the healthcare industry.

Best Scientists Citing Bruce W. S. Robinson

Trending Scientists

Recently Published Articles